Brief: Tianjin Development Says Unit To Subscribe For Wealth Management Product For RMB20 Million
01/08/2023 11:22
Aug 1 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* LISHENG PHARMACEUTICAL TO SUBSCRIBE FOR WEALTH MANAGEMENT
PRODUCT IN SUBSCRIPTION AMOUNT OF RMB20 MILLION
Further company coverage: 0882.HK
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln